Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids

Volume: 11, Issue: 1
Published: May 27, 2020
Abstract
High-grade serous ovarian cancer (HG-SOC)—often referred to as a “silent killer”—is the most lethal gynecological malignancy. The fallopian tube (murine oviduct) and ovarian surface epithelium (OSE) are considered the main candidate tissues of origin of this cancer. However, the relative contribution of each tissue to HG-SOC is not yet clear. Here, we establish organoid-based tumor progression models of HG-SOC from murine oviductal and OSE...
Paper Details
Title
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids
Published Date
May 27, 2020
Volume
11
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.